190 related articles for article (PubMed ID: 1977017)
1. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.
Garson JA; Tuke PW; Makris M; Briggs M; Machin SJ; Preston FE; Tedder RS
Lancet; 1990 Oct; 336(8722):1022-5. PubMed ID: 1977017
[TBL] [Abstract][Full Text] [Related]
2. Serological response and detection of viraemia in acute hepatitis C virus infection.
Dourakis S; Brown J; Kumar U; Karayiannis P; Kernoff P; Chiba J; Ohba H; Miyamura T; Saito I; Monjardino J
J Hepatol; 1992 Mar; 14(2-3):370-6. PubMed ID: 1380025
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatitis C viral sequences in non-A, non-B hepatitis.
Weiner AJ; Kuo G; Bradley DW; Bonino F; Saracco G; Lee C; Rosenblatt J; Choo QL; Houghton M
Lancet; 1990 Jan; 335(8680):1-3. PubMed ID: 1967327
[TBL] [Abstract][Full Text] [Related]
4. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.
Shibata M; Morishima T; Kudo T; Maki T; Maki S; Nagai Y
Blood; 1991 Mar; 77(6):1157-60. PubMed ID: 1705830
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.
Brillanti S; Garson JA; Tuke PW; Ring C; Briggs M; Masci C; Miglioli M; Barbara L; Tedder RS
J Med Virol; 1991 Jun; 34(2):136-41. PubMed ID: 1716296
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia.
Tedder RS; Briggs M; Ring C; Tuke PW; Jones P; Savidge GF; Rodgers B; Garson JA
Br J Haematol; 1991 Nov; 79(3):512-5. PubMed ID: 1721527
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.
Simmonds P; Zhang LQ; Watson HG; Rebus S; Ferguson ED; Balfe P; Leadbetter GH; Yap PL; Peutherer JF; Ludlam CA
Lancet; 1990 Dec; 336(8729):1469-72. PubMed ID: 1979093
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
11. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
[TBL] [Abstract][Full Text] [Related]
15. A dynamic study of viraemia in chronic hepatitis C infection.
Meng ZD; Sun YD; Sun DG; Liu CY; Copland J; Gowans EJ
J Gastroenterol Hepatol; 1994; 9(3):242-4. PubMed ID: 7519895
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the antibody against core protein of hepatitis C virus.
Ohkoshi S; Watanabe M; Kuwana K; Tawaraya H; Kamimura T; Asakura H
Gastroenterol Jpn; 1993 May; 28 Suppl 5():80-3. PubMed ID: 7689513
[TBL] [Abstract][Full Text] [Related]
17. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens.
Wang JT; Wang TH; Lin JT; Sheu JC; Lee CZ; Chen DS
Vox Sang; 1992; 62(1):21-4. PubMed ID: 1374579
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
[TBL] [Abstract][Full Text] [Related]
19. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
20. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
